CLINICAL_TRIALS
trial_result
· 2024-06-26
Clinical Trial Update: A Study to Test How Kidney Problems Influence the Blood Concentrations of Efgartigimod [Phase 1]
Summary
Completed Phase 1 pharmacokinetic study evaluating how renal impairment influences blood concentrations of efgartigimod.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: argenx | Conditions: Renal Impairment | Phase 1 | Status: COMPLETED